AMGN vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 07, 2026

AMGN

50.9
AI Score
VS
AMGN Wins

MRNA

48.5
AI Score

Investment Advisor Scores

AMGN

51score
Recommendation
HOLD

MRNA

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AMGN MRNA Winner
Revenue 18.67B 534.00M AMGN
Net Income 4.19B -2.13B AMGN
Net Margin 22.5% -397.9% AMGN
Operating Income 6.18B -2.20B AMGN
ROE 35.9% -31.4% AMGN
ROA 4.4% -19.4% AMGN
Total Assets 95.64B 10.96B AMGN
Cash 13.99B 1.72B AMGN
Debt/Equity 4.90 0.09 MRNA
Current Ratio 1.37 2.29 MRNA
Free Cash Flow 4.97B -1.25B AMGN

Relative Price Performance (Last 90 Days)

AMGN 1M: +12.7% · 3M: +24.5% MRNA 1M: -23.7% · 3M: +20.3%

Current Technical Phase

AMGN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 72

RSI (14): 71.5 · Price: $409.87

MRNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $58.39

Fundamentals Snapshot

Metric AMGN MRNA
Market Cap
Forward P/E 17.5 -11.0
Trailing P/E 25.3
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% -0.7%
Operating Margin 0.4% -5.6%
EPS 15.99 -7.88
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, AMGN is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.